Valcivir 500 mg Cipla
€48.00
Valcivir 500 mg Cipla: Your Effective Solution Against Viral Infections
Valcivir 500 mg Cipla is a potent antiviral medication designed to combat infections caused by the herpes simplex virus and zoster virus. By inhibiting viral DNA replication, this medicine plays a crucial role in managing and reducing the severity of viral outbreaks. Whether you are dealing with cold sores or shingles, Valcivir can help alleviate symptoms and promote faster recovery. With a recommended dosage of 500 mg taken twice daily, this medication provides a reliable means to control and manage your condition effectively.
Key Benefits of Valcivir 500 mg Cipla
Understanding the benefits of Valcivir 500 mg Cipla can empower you to make an informed decision about your health. This product offers several distinct advantages for those looking to manage viral infections effectively. Here are some key benefits you may experience:
- Reduces the duration of herpes outbreaks
- Decreases the severity of symptoms associated with viral infections
- Low risk of adverse liver effects
- No significant impact on blood pressure
These advantages underline the importance of incorporating Valcivir 500 mg Cipla into your treatment plan. Whether you’re experiencing a primary outbreak or a recurrent one, you can rely on this medication to provide significant relief while minimizing complications.
Long-Term Effects and Practical Benefits of Valcivir 500 mg Cipla
When considering any antiviral treatment, understanding the long-term effects is essential, and Valcivir 500 mg Cipla is no exception. Its sustained efficacy means that with consistent use, you can effectively manage outbreaks over time. With a half-life of 2.5 to 3.3 hours, the medication’s impact continues to work in controlling symptoms even after the initial dose. Storing at optimal conditions—15°C to 25°C—ensures the medication remains effective throughout its shelf life.
The formulation of Valcivir, known chemically as Valacyclovir hydrochloride, is designed to target and inhibit the replication of the herpes virus without significant side effects. Consequently, individuals can experience fewer interruptions in their daily lives while benefiting from its antiviral properties. Moreover, the negligible risk of water retention and low hepatotoxicity adds an extra layer of assurance for users.
Valcivir 500 mg Cipla is an important part of your healthcare routine if you frequently encounter viral infections. It closes the gap between discomfort and recovery, paving the way for a healthier, more manageable life.
| Water Retention | Negligible |
|---|---|
| Hepatotoxicity | Low risk |
| Lab Test | Not typically required for monitoring |
| Strength | 500 mg |
| Also known as | Valaciclovir |
| Blood pressure | No significant impact |
| Trade name | Valtrex |
| Storage conditions | Store at 15В°C to 25В°C (59В°F to 77В°F) |
| Chemical name | Valacyclovir hydrochloride |
| Formula | C13H20N6O4В·HCl |
| Substance class | Antiviral |
| Main action | Inhibits viral DNA replication |
| Half-life | 2.5 to 3.3 hours |
| Dosage (medical) | 500 mg to 1000 mg taken twice daily |
| Dosage (sports) | Not applicable |
| Effects | Reduces the duration and severity of herpes virus outbreaks |
| Side effects | Nausea, headache, vomiting, dizziness |
| Use in sports | None |
| Manufacturer | Cipla |
| 5 |
|
0 |
| 4 |
|
0 |
| 3 |
|
0 |
| 2 |
|
0 |
| 1 |
|
0 |





Reviews
There are no reviews yet.